TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
2004 · Immunity · 717 citations
https://doi.org/10.1016/j.immuni.2004.07.020
C
Christoph Schramm
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
638
Papers
22.2K
Citations
78
h-index
220
i10-index
Christoph Schramm is an academic researcher. The author has contributed to research in topics: Liver Diseases and Immunity & Liver Disease Diagnosis and Treatment & Pediatric Hepatobiliary Diseases and Treatments. The author has an h-index of 78, co-authored 543 publications.
ORCID: 0000-0002-4264-1928Papers by this author
worksPatient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
2017 · Gastroenterology · 505 citations
https://doi.org/10.1053/j.gastro.2017.02.038
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation
2022 · Cell · 465 citations
https://doi.org/10.1016/j.cell.2022.07.003
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
2013 · Nature Genetics · 389 citations
https://doi.org/10.1038/ng.2616
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
2023 · Journal of Hepatology · 153 citations
https://doi.org/10.1016/j.jhep.2023.02.027
Persistent SOMAtic symptoms ACROSS diseases — from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)
2022 · BMJ Open · 110 citations
https://doi.org/10.1136/bmjopen-2021-057596
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat